Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc.2019. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates.
© 2022 Cable News Network. A Warner Bros. Discovery Company. All Rights Reserved.
CNN Sans⢠& © 2016 Cable News Network.
FAQs
Shareholders
| Name | Equities | % |
|---|
| The Vanguard Group, Inc. 6.988 % | 26,594,293 | 6.988 % |
| Stéphane Bancel 5.530 % | 21,045,091 | 5.530 % |
| Baillie Gifford & Co. 4.603 % | 17,516,865 | 4.603 % |
| Flagship Pioneering 3.386 % | 12,886,743 | 3.386 % |
6 more rowsTop Shareholders
The Vanguard Group, Inc. BlackRock, Inc. State Street Global Advisors, Inc. Coatue Management, L.L.C.
How many shares does Moderna have? ›
Moderna Shares Outstanding: 380.59M for July 31, 2023.
Who owns the most stock in CNN? ›
Top 10 Owners of News Corp
| Stockholder | Stake | Shares owned |
|---|
| T. Rowe Price Associates, Inc. (I... | 18.40% | 69,839,654 |
| The Vanguard Group, Inc. | 13.71% | 52,023,708 |
| Independent Franchise Partners LL... | 8.30% | 31,493,424 |
| SSgA Funds Management, Inc. | 4.89% | 18,581,500 |
6 more rowsBlackRock--which owns 8% of AstraZeneca and 6.8% of Pfizer--is encouraging discussions between the two companies, according to Bloomberg, which cited anonymous sources. As AstraZeneca's largest shareholder, BlackRock could carry considerable weight in the ongoing bidding process.
How is Moderna making money? ›
Moderna Revenue Breakdown: Product sales, 96%; Grant revenue, 4%; Collaboration revenue, a tiny fraction. * Sales of Moderna's COVID-19 vaccine accounted for all of the company's product sales in Q4 FY 2021.
How much debt is Moderna in? ›
Moderna long term debt for 2022 was $0.912B, a 52.25% increase from 2021. Moderna long term debt for 2021 was $0.599B, a 444.55% increase from 2020. Moderna long term debt for 2020 was $0.11B, a 184.32% increase from 2019.
What is the highest stock price for Moderna? ›
The all-time high Moderna stock closing price was 484.47 on August 09, 2021. The Moderna 52-week high stock price is 217.25, which is 116.8% above the current share price.
Who owns Pfizer stock? ›
The top shareholders of Pfizer are Frank A. D'Amelio, Mikael Dolsten, Albert Bourla, Vanguard Group Inc., BlackRock Inc. (BLK), and State Street Corp. (STT).
Who is Google's biggest shareholder? ›
Google (NASDAQ: GOOGL) is owned by 62.18% institutional shareholders, 3.56% Google insiders, and 34.27% retail investors. Brin Sergey is the largest individual Google shareholder, owning 367.31M shares representing 2.91% of the company. Brin Sergey's Google shares are currently valued at $49.12B.
Vanguard set out in 1975 under a radical ownership structure that remains unique in the asset management industry. Our company is owned by its member funds, which in turn are owned by fund shareholders. With no outside owners to satisfy, we focus squarely on meeting the investment needs of our clients.
Who are the shareholders of mRNA? ›
Largest shareholders include Baillie Gifford & Co, Vanguard Group Inc, BlackRock Inc., State Street Corp, Flagship Pioneering Inc., VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VWIGX - Vanguard International Growth Fund Investor Shares, VFINX - Vanguard 500 Index Fund Investor Shares, Coatue ...
Who are the leaders of mRNA vaccines? ›
Penn Medicine is home to the breakthrough messenger ribonucleic acid (mRNA) technology that enabled the highly successful COVID-19 vaccines from Moderna and Pfizer-BioNTech.
Who are the pioneers of the mRNA vaccine? ›
The company's founders, biochemist Katalin Karikó and immunologist Drew Weissman, both then at the University of Pennsylvania (UPenn) in Philadelphia, had made what some now say is a key finding: that altering part of the mRNA code helps synthetic mRNA to slip past the cell's innate immune defences.
